25 Although each subtype has unique characteristics, they may overlap in some respects
GLP-1 medications are changing how we think about treating obesity and metabolic disease, says Robert Kushner, MD, professor of medicine at Northwestern University and an obesity medicine specialist
It is a recalibration of the hunger and satiety signaling system
Agarwal A, Sengupta P, Durairajanayagam D
A better and more defensible statement is this: retatrutide may create a better body-composition opportunity, but actual muscle retention or gain still depends on training, protein, recovery, and treatment design
youre on a guided path to a healthier you, with us beside you every step of the way